Norfloxacin Lactate

乳酸诺氟沙星

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameNorfloxacin Lactate
Drug Alias NamenorfloxacinonorfloxacineNorfloxacinum
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionTopoisomerase IV inhibitorsBacterial DNA gyrase inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsAcute BronchitisCystitisPyelonephritis +[8] 
Global Approved IndicationsAcute BronchitisCystitisPyelonephritis +[8] 
Approved Indications in ChinaAcute BronchitisCystitisPyelonephritis +[8] 
Original Approved Country/TerritoryMainland China
Original Approved Date1996/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsAcute BronchitisCystitisPyelonephritis +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG